Instituto de Investigaciones Biomédicas (BIOMED), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Facultad de Ciencias Médicas, Pontificia Universidad Católica Argentina (UCA), Av. Alicia Moreau de Justo 1600, 3er piso (1107 AAZ), Buenos Aires, Argentina.
Cátedra de Física, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Endocrine. 2019 Nov;66(2):266-277. doi: 10.1007/s12020-019-01936-7. Epub 2019 May 5.
Hypothyroidism has been shown to induce immunosuppression and both the thyroid status and immunity are affected by zinc deficiency. However, the impact of hypothyroidism on zinc metabolism and its possible relationship with the immune status has not yet been deeply explored. Here, our aim was to study whether hypothyroidism may alter zinc metabolism and thus lead to the impairment of T lymphocyte activity.
Variations in the distribution of zinc in the body were evaluated in PTU-treated hypothyroid mice. The effects of hypothyroidism and zinc deficiency were studied on T lymphocyte proliferation after stimulation both in vitro and in vivo. For in vitro assays, thyroid hormone-free or zinc chelator (TPEN or DTPA)-supplemented media were used. For in vivo assays, lymphocyte activity was evaluated in cells from hypothyroid, T3-treated, and zinc-supplemented mice.
Hypothyroid mice showed lower levels of zinc in femur and lymph nodes than controls. T3 and zinc supplementation reversed these effects. In vitro, both thyroid hormone and zinc deficiency led to a decreased response to mitogen stimulation. However, only zinc deficiency was able to induce lymphocyte apoptosis. Mitogen-stimulated T cells from hypothyroid mice showed impaired proliferation, accompanied by decreased activation of PKC and lower levels of p-ERK, effects that were reversed by T3 replacement or zinc supplementation.
Our results show an important role of zinc deficiency in hypothyroid-mediated T-cell suppression and suggest the importance of evaluating zinc levels and restoring them when necessary to maintain an efficient immune response in hypothyroid patients.
甲状腺功能减退症已被证明可诱导免疫抑制,甲状腺状态和免疫均受锌缺乏的影响。然而,甲状腺功能减退症对锌代谢的影响及其与免疫状态的可能关系尚未得到深入探讨。在这里,我们的目的是研究甲状腺功能减退症是否可能改变锌代谢,从而导致 T 淋巴细胞活性受损。
在丙硫氧嘧啶(PTU)治疗的甲状腺功能减退症小鼠中评估锌在体内的分布变化。研究了甲状腺功能减退症和缺锌对体外和体内刺激后 T 淋巴细胞增殖的影响。在体外实验中,使用无甲状腺激素或锌螯合剂(TPEN 或 DTPA)补充的培养基。在体内实验中,评估甲状腺功能减退症、T3 治疗和补锌小鼠的淋巴细胞活性。
甲状腺功能减退症小鼠的股骨和淋巴结中的锌水平低于对照组。T3 和锌补充可逆转这些影响。在体外,甲状腺激素和缺锌均导致对有丝分裂原刺激的反应降低。然而,只有缺锌才能诱导淋巴细胞凋亡。来自甲状腺功能减退症小鼠的有丝分裂原刺激的 T 细胞增殖能力受损,同时伴随着 PKC 激活降低和 p-ERK 水平降低,这些效应可通过 T3 替代或补锌来逆转。
我们的研究结果表明,缺锌在甲状腺功能减退症介导的 T 细胞抑制中起着重要作用,并提示在甲状腺功能减退症患者中评估锌水平并在必要时恢复它们以维持有效的免疫反应的重要性。